Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9503]
News [23297]
Articles [1985]
Editorials [134]
Conferences [463]
elearning [298]
ASCO: Childhood cancer survivors at risk of post-traumatic stress disorder
Dr. Margaret Stuber - Los Angeles David Geffen School of Medicine, Los Angeles...
ASCO: Childhood cancer survivors at risk of post-traumatic stress disorder ( Dr. Margaret Stuber - Los Angeles David Geffen School of Medicine, Los Angeles, California, USA )
18 Jun 2009
ASCO: Maintenance therapy for NSCLC
Dr. Vincent A. Miller - MD Memorial Sloan-Kettering Cancer Center, New York...
ASCO: Maintenance therapy for NSCLC ( Dr. Vincent A. Miller - MD Memorial Sloan-Kettering Cancer Center, New York, USA )
18 Jun 2009
ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease...
Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital...
ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer ( Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital, US )
17 Jun 2009
ASCO: Experimental targeted therapy improves progression-free survival for...
Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US
ASCO: Experimental targeted therapy improves progression-free survival for advanced NSCLC ( Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US )
17 Jun 2009
Oestrogen and progestin therapy increases NSCLC risk
Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US
Oestrogen and progestin therapy increases NSCLC risk ( Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US )
17 Jun 2009
AACR 2009: Circulating tumour cells as biomarkers
Dr Howard Scher - Sloan Kettering Memorial Cancer Center
AACR 2009: Circulating tumour cells as biomarkers ( Dr Howard Scher - Sloan Kettering Memorial Cancer Center )
5 Jun 2009
NHS health care and the US health system
Exclusive interview with Professor Karol Sikora - Medical Director of Cancer...
NHS health care and the US health system ( Exclusive interview with Professor Karol Sikora - Medical Director of Cancer Partners UK )
28 May 2009
AACR 2009: Tackling the p53 gene and side effects
Professor David Lane - Director of the Cancer Research UK Transformation...
AACR 2009: Tackling the p53 gene and side effects ( Professor David Lane - Director of the Cancer Research UK Transformation Research Group, University of Dundee )
18 May 2009
AACR 2009: Common genetic variations and predisposition to cancer
Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )
14 May 2009
AACR 2009: Chemokine inhibitors to prevent tumour growth
Prof Alberto Mantovani - Professor of General Pathology, University of Milan
AACR 2009: Chemokine inhibitors to prevent tumour growth ( Prof Alberto Mantovani - Professor of General Pathology, University of Milan )
14 May 2009
AACR 2009: Cancer stem cells and leukaemia
Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School...
AACR 2009: Cancer stem cells and leukaemia ( Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School of Medicine )
14 May 2009
AACR 2009: 100 years of AACR
Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )
14 May 2009

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation